570 Stock Overview China Traditional Chinese Medicine Holdings Co. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
China Traditional Chinese Medicine Holdings Co. Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for China Traditional Chinese Medicine Holdings Historical stock prices Current Share Price HK$2.27 52 Week High HK$4.46 52 Week Low HK$2.12 Beta 0.76 1 Month Change 4.61% 3 Month Change -47.82% 1 Year Change -41.94% 3 Year Change -44.63% 5 Year Change -38.48% Change since IPO -42.53%
Recent News & Updates
Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others. Oct 19 Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others. Oct 18
First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023) Sep 28
China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments Sep 27
New major risk - Revenue and earnings growth Sep 05
First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023) Aug 30 See more updates
Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others. Oct 19 Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others. Oct 18
First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023) Sep 28
China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments Sep 27
New major risk - Revenue and earnings growth Sep 05
First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023) Aug 30
China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2024 Results on Aug 28, 2024 Aug 16
Investor sentiment deteriorates as stock falls 15% Jun 27 China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes
China Traditional Chinese Medicine Holdings Co. Limited, Annual General Meeting, Jun 14, 2024 Mar 22
Full year 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.15 in FY 2022) Mar 22
Investor sentiment improves as stock rises 26% Feb 28
Less than half of directors are independent Feb 23
Investor sentiment improves as stock rises 15% Feb 08
China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023 Jan 29
Investor sentiment deteriorates as stock falls 20% Jan 08
Investor sentiment improves as stock rises 17% Sep 25
China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023 Aug 30
First half 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.082 in 1H 2022) Aug 30
China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 18
China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 Jul 30
China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2022 May 31
Upcoming dividend of HK$0.052 per share at 1.3% yield May 26
China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022 May 06
Full year 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.38 in FY 2021) Mar 26
China Traditional Chinese Medicine Holdings Co. Limited Provides Earning Guidance for the Year Ended 31 December 2022 Jan 17
Investor sentiment improved over the past week Dec 09
China Traditional Chinese Medicine Holdings Co. Limited Announces Management Changes Nov 19
Less than half of directors are independent Nov 16
China Traditional Chinese Medicine Holdings Co. Limited Do Not Recommend the Payment of an Interim Dividend for the Six Months Ended 30 June 2022 Aug 27
First half 2022 earnings released: EPS: CN¥0.082 (vs CN¥0.18 in 1H 2021) Aug 27
China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2022 Results on Aug 26, 2022 Aug 17
Investor sentiment deteriorated over the past week Jul 14
China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022 Jul 13
China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2021, Payable on 29 July 2022 Jun 25
Upcoming dividend of HK$0.074 per share Jun 22
China Traditional Chinese Medicine Holdings Co. Limited Recommends Final Dividend for the Year Ended 31 December 2021 Jun 03
China Traditional Chinese Medicine Holdings Co. Limited Recommends Final Dividend for the Year Ended 31 December 2021 Jun 02
China Traditional Chinese Medicine Holdings Co. Limited Announces Executive Changes May 13
Full year 2021 earnings released: EPS: CN¥0.38 (vs CN¥0.33 in FY 2020) Apr 30
Less than half of directors are independent Apr 27
Full year 2021 earnings released: EPS: CN¥0.38 (vs CN¥0.33 in FY 2020) Mar 29
Investor sentiment improved over the past week Mar 22
Now 20% undervalued Mar 05
Investor sentiment deteriorated over the past week Jan 27
Investor sentiment improved over the past week Dec 29
First half 2021 earnings released: EPS CN¥0.18 (vs CN¥0.14 in 1H 2020) Sep 30
Upcoming dividend of HK$0.067 per share Aug 26
First half 2021 earnings released: EPS CN¥0.18 (vs CN¥0.14 in 1H 2020) Aug 23
Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.32 in FY 2019) Apr 24
Full year 2020 earnings released: EPS CN¥0.33 (vs CN¥0.32 in FY 2019) Mar 31
China Traditional Chinese Medicine Holdings Co. Limited to Report Fiscal Year 2020 Results on Mar 30, 2021 Mar 19
New 90-day high: HK$4.77 Feb 20
New 90-day high: HK$4.05 Jan 18
New 90-day high: HK$3.84 Dec 31
New 90-day high: HK$3.65 Dec 01
New 90-day low: HK$3.14 Oct 29
New 90-day low: HK$3.15 Oct 05
First half earnings released Sep 29
China Traditional Chinese Medicine Holdings Co. Limited Not Recommends Interim Dividend for the Six Months Ended 30 June 2020 Sep 28
New 90-day low - HK$3.31 Aug 31
China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2020 Results on Aug 21, 2020 Aug 23
First half earnings released Aug 22
China Traditional Chinese Medicine Holdings Co. Limited Recommends No Interim Dividend for the Six Months Ended 30 June 2020 Aug 22 Shareholder Returns 570 HK Pharmaceuticals HK Market 7D -4.2% -1.9% -0.5% 1Y -41.9% -3.9% 19.9%
See full shareholder returns
Return vs Market: 570 underperformed the Hong Kong Market which returned 19.9% over the past year.
Price Volatility Is 570's price volatile compared to industry and market? 570 volatility 570 Average Weekly Movement 10.8% Pharmaceuticals Industry Average Movement 6.4% Market Average Movement 8.8% 10% most volatile stocks in HK Market 18.6% 10% least volatile stocks in HK Market 4.1%
Stable Share Price: 570 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 570's weekly volatility (11%) has been stable over the past year.
About the Company China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of traditional Chinese medicine (TCM) and pharmaceutical products in the People's Republic of China. It operates through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. The company manufactures, manages, and sells concentrated TCM granules, and TCM health care products and decoction pieces under the Yi Fang, Tian Jiang, and Tong Ji Tang brand names; and offers Chinese medical related healthcare solutions including Chinese medical consultation and diagnosis, TCM physiotherapy, and prescription with concentrated TCM granules through offline medical institutions.
Show more China Traditional Chinese Medicine Holdings Co. Limited Fundamentals Summary How do China Traditional Chinese Medicine Holdings's earnings and revenue compare to its market cap? 570 fundamental statistics Market cap HK$11.43b Earnings (TTM ) HK$977.74m Revenue (TTM ) HK$18.34b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 570 income statement (TTM ) Revenue CN¥17.20b Cost of Revenue CN¥8.63b Gross Profit CN¥8.58b Other Expenses CN¥7.66b Earnings CN¥917.44m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 12:58 End of Day Share Price 2024/12/20 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources China Traditional Chinese Medicine Holdings Co. Limited is covered by 25 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Ling Zhang BNP Paribas Securities (Asia) Yue-Kwong Lui BOCOM International Securities Limited Helena Qiu CCB International Securities Limited
Show 22 more analysts 
